XLON
PRU
Market cap33bUSD
Jun 18, Last price
1,010.00GBP
1D
-0.15%
1Q
-4.90%
Jan 2017
-25.08%
Name
Prudential PLC
Chart & Performance
P/E
14.58
P/S
4.09
EPS
0.91
Div Yield, %
2.08%
Shrs. gr., 5y
16.03%
Rev. gr., 5y
-38.66%
Revenues
8.14b
-32.01%
Net income
2.29b
+34.33%
CFO
3.61b
+333.77%
Dividend
Sep 05, 20246.84 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating through its various divisions, Prudential plc delivers financial services, encompassing life and health coverage, retirement planning, and investment management, to clients across Asia and Africa. Its insurance portfolio includes health and comprehensive protection plans, alongside various savings instruments like participating, unit-linked, and conventional policies. Furthermore, the firm offers specialized coverage for prevalent critical conditions such as cancer, strokes, and heart attacks, in addition to safeguards against tropical ailments like dengue, malaria, and measles. Beyond insurance, Prudential oversees investment capital for both corporate and private clients, employing a diverse range of strategies including equities, fixed income, multi-asset allocations, quantitative models, and alternative investments. Distribution of its offerings is facilitated via its network of agents, banking partners, and independent brokers. Established in 1848, the company maintains its primary corporate office in London, United Kingdom.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||